Adult Attention-Deficit Hyperactivity Disorder/Substance Use Disorder Dual Disorder Patients: A Dual Disorder Unit Point of View.
ADHD Clinical presentations
Adult ADHD
Caffeine
Cocaine Use Disorder
Substance Use Disorder
Journal
Current topics in behavioral neurosciences
ISSN: 1866-3370
Titre abrégé: Curr Top Behav Neurosci
Pays: Germany
ID NLM: 101535383
Informations de publication
Date de publication:
2022
2022
Historique:
pubmed:
5
5
2022
medline:
6
8
2022
entrez:
4
5
2022
Statut:
ppublish
Résumé
Substance Use Disorders (SUDs) are often associated with Attention-Deficit Hyperactivity Disorder (ADHD) in adult populations due to multiple neurobiological, genetic, and psychosocial risk factors. This chapter provides a picture of the clinical aspects of adults with both ADHD and SUDs at treatment entry into a Dual Disorder Unit introducing the concept of different types of craving that may lead to substance use and abuse. At treatment entry, the presence of different comorbid SUD clusters, characterized by either stimulants/alcohol or by the use of cannabinoids, has not been shown to influence ADHD-specific symptomatology or severity, despite being crucial for the identification of a specific type of craving. We identified four clinical presentations of adult ADHD: Emotional Dysregulation, Substance Use, Core-ADHD Symptoms, and Positive Emotionality variants, that offer a practical guide in diagnosing and managing adult ADHD patients. Although the evidence of an effective medical treatment for Cocaine Use Disorder is insufficient, in our experience, toxicomanic behavior during stimulant treatment is sharply reduced in ADHD patients with cocaine addiction. Moreover, caffeinated compounds in military soldiers with ADHD may help reduce ADHD symptoms, making caffeine a potential pharmacological tool worth further investigation. Finally, substance use comorbidity does not influence treatment retention rate.
Identifiants
pubmed: 35507285
doi: 10.1007/7854_2022_335
doi:
Substances chimiques
Central Nervous System Stimulants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
179-198Informations de copyright
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Références
Abel KF, Bramness JG, Martinsen EW (2014) Stimulant medication for ADHD in opioid maintenance treatment. J Dual Diagn 10(1):32–38
pubmed: 25392060
doi: 10.1080/15504263.2013.867657
Adler L, Cohen J (2004) Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 27(2):187–201
pubmed: 15063992
doi: 10.1016/j.psc.2003.12.003
Anker E, Haavik J, Heir T (2020) Alcohol and drug use disorders in adult attention-deficit/hyperactivity disorder: prevalence and associations with attention-deficit/hyperactivity disorder symptom severity and emotional dysregulation. World J Psychiatry 10(9):202–211
pubmed: 33014721
pmcid: 7515748
doi: 10.5498/wjp.v10.i9.202
Arnsten AF (2009) The emerging neurobiology of attention deficit hyperactivity disorder: the key role of the prefrontal association cortex. J Pediatr 154(5):I-s43
Bae EJ, Kim EB, Choi BR, Won SH, Kim JH et al (2019) The relationships between addiction to highly caffeinated drinks, burnout, and attention-deficit/hyperactivity disorder. Soa Chongsonyon Chongsin Uihak 30(4):153–160
pubmed: 32595336
pmcid: 7298905
Barkley RA (2015) Chapter: executive functioning and self-regulation viewed as an extended phenotype: implications of the theory for ADHD and its treatment. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment, 4th edn. The Guilford Press, New York
Barkley RA, Fischer M (2010) The unique contribution of emotional impulsiveness to impairment in major life activities in hyperactive children as adults. J Am Acad Child Adolesc Psychiatry 49(5):503–513
pubmed: 20431470
Barkley RA, Murphy KR (2010) Deficient emotional self-regulation in adults with ADHD: the relative contributions of emotional impulsiveness and ADHD symptoms to adaptive impairments in major life activities. J ADHD Relat Disord:15–28
Barratt ES, Beaver W, White R (1974) The effects of marijuana on human sleep patterns. Biol Psychiatry 8(1):47–54
pubmed: 4361028
Biederman J, Petty CR, Monuteaux MC, Evans M, Parcell T et al (2009) The child behavior checklist-pediatric bipolar disorder profile predicts a subsequent diagnosis of bipolar disorder and associated impairments in ADHD youth growing up: a longitudinal analysis. J Clin Psychiatry 70(5):732–740
pubmed: 19389330
pmcid: 3066229
doi: 10.4088/JCP.08m04821
Biederman J, Spencer T, Lomedico A, Day H, Petty CR, Faraone SV (2012) Deficient emotional self-regulation and pediatric attention deficit hyperactivity disorder: a family risk analysis. Psychol Med 42(3):639–646
pubmed: 21861953
doi: 10.1017/S0033291711001644
Bush G (2011) Cingulate, frontal, and parietal cortical dysfunction in attention-deficit/hyperactivity disorder. Biol Psychiatry 69(12):1160–1167
pubmed: 21489409
pmcid: 3109164
doi: 10.1016/j.biopsych.2011.01.022
Carpentier PJ, Levin FR (2017) Pharmacological treatment of ADHD in addicted patients: what does the literature tell us? Harv Rev Psychiatry 25(2):50–64
pubmed: 28272130
pmcid: 5518741
doi: 10.1097/HRP.0000000000000122
Chait LD (1990) Subjective and behavioral effects of marijuana the morning after smoking. Psychopharmacology 100(3):328–333
pubmed: 2315429
doi: 10.1007/BF02244601
Cipollone G, Gehrman P, Manni C, Pallucchini A, Maremmani AGI et al (2020) Exploring the controversial role of caffeine in adult-ADHD symptom severity of us army soldiers. J Clin Med – MDPI 93788
De Alwis D, Lynskey MT, Reiersen AM, Agrawal A (2014) Attention-deficit/hyperactivity disorder subtypes and substance use and use disorders in nesarc. Addict Behav 39(8):1278–1285
pubmed: 24821471
pmcid: 4135513
doi: 10.1016/j.addbeh.2014.04.003
De Graaf R, Kessler RC, Fayyad J, Ten Have M, Alonso J et al (2008) The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the who world mental health survey initiative. Occup Environ Med 65(12):835–842
pubmed: 18505771
doi: 10.1136/oem.2007.038448
Epstein JN, Loren RE (2013) Changes in the definition of ADHD in dsm-5: subtle but important. Neuropsychiatry (London) 3(5):455–458
doi: 10.2217/npy.13.59
Ercan ES, Coskunol H, Varan A, Toksoz K (2003) Childhood attention deficit/hyperactivity disorder and alcohol dependence: a 1-year follow-up. Alcohol Alcohol 38(4):352–356
pubmed: 12814903
doi: 10.1093/alcalc/agg084
Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8(11):1481–1489
pubmed: 16251991
doi: 10.1038/nn1579
Faraone SV, Wilens T (2003) Does stimulant treatment lead to substance use disorders? J Clin Psychiatry 64(Suppl):119–113
Farsad-Naeimi A, Asjodi F, Omidian M, Askari M, Nouri M et al (2020) Sugar consumption, sugar sweetened beverages and attention deficit hyperactivity disorder: a systematic review and meta-analysis. Complement Ther Med 53:102512
pubmed: 33066852
doi: 10.1016/j.ctim.2020.102512
Franke B, Michelini G, Asherson P, Banaschewski T, Bilbow A et al (2018) Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. Eur Neuropsychopharmacol 28(10):1059–1088
pubmed: 30195575
pmcid: 6379245
doi: 10.1016/j.euroneuro.2018.08.001
Gudjonsson GH, Sigurdsson JF, Sigfusdottir ID, Young S (2012) An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use. J Child Psychol Psychiatry 53(3):304–312
pubmed: 22066497
doi: 10.1111/j.1469-7610.2011.02489.x
Hinshaw SP (2002) Preadolescent girls with attention-deficit/hyperactivity disorder: I. Background characteristics, comorbidity, cognitive and social functioning, and parenting practices. J Consult Clin Psychol 70(5):1086–1098
pubmed: 12362959
doi: 10.1037/0022-006X.70.5.1086
Hinshaw SP, Owens EB, Sami N, Fargeon S (2006) Prospective follow-up of girls with attention-deficit/hyperactivity disorder into adolescence: evidence for continuing cross-domain impairment. J Consult Clin Psychol 74(3):489–499
pubmed: 16822106
doi: 10.1037/0022-006X.74.3.489
Holtmann M, Buchmann AF, Esser G, Schmidt MH, Banaschewski T, Laucht M (2011) The child behavior checklist-dysregulation profile predicts substance use, suicidality, and functional impairment: a longitudinal analysis. J Child Psychol Psychiatry 52(2):139–147
pubmed: 20854363
doi: 10.1111/j.1469-7610.2010.02309.x
Ishak WW, Ugochukwu C, Bagot K, Khalili D, Zaky C (2012) Energy drinks: psychological effects and impact on Well-being and quality of life-a literature review. Innov Clin Neurosci 9(1):25–34
pubmed: 22347688
pmcid: 3280075
Jang C-B, Kim H-Y (2012) The relationship between attention deficit hyperactivity disorder, dietary habit and caffeine intake in upper-grade elementary school children. Korean J Nutr 45(6):522–530
doi: 10.4163/kjn.2012.45.6.522
Kamimori GH, Mclellan TM, Tate CM, Voss DM, Niro P, Lieberman HR (2015) Caffeine improves reaction time, vigilance and logical reasoning during extended periods with restricted opportunities for sleep. Psychopharmacology 232(12):2031–2042
pubmed: 25527035
doi: 10.1007/s00213-014-3834-5
Kessler RC, Adler L, Barkley R, Biederman J, Conners CK et al (2006) The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am J Psychiatry 163(4):716–723
pubmed: 16585449
pmcid: 2859678
doi: 10.1176/ajp.2006.163.4.716
Kohlboeck G, Heitmueller D, Neumann C, Tiesler C, Heinrich J et al (2013) Is there a relationship between hyperactivity/inattention symptoms and poor oral health? Results from the giniplus and lisaplus study. Clin Oral Investig 17(5):1329–1338
pubmed: 22927131
doi: 10.1007/s00784-012-0829-7
Konstenius M, Jayaram-Lindstrom N, Guterstam J, Beck O, Philips B et al (2014) Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial. Addiction 109(3):440–449
pubmed: 24118269
doi: 10.1111/add.12369
Leon MR (2000) Effects of caffeine on cognitive, psychomotor, and affective performance of children with attention-deficit/hyperactivity disorder. J Atten Disord 4(1):27–47
doi: 10.1177/108705470000400103
Levin FR, Evans SM, Brooks DJ, Kalbag AS, Garawi F et al (2006) Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend 81(2):137–148
pubmed: 16102908
doi: 10.1016/j.drugalcdep.2005.06.012
Levin FR, Mariani JJ, Specker S, Mooney M, Mahony A et al (2015) Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit/hyperactivity disorder and cocaine use disorder: a randomized clinical trial. JAMA Psychiat 72(6):593–602
doi: 10.1001/jamapsychiatry.2015.41
Levin FR, Choi CJ, Pavlicova M, Mariani JJ, Mahony A et al (2018) How treatment improvement in ADHD and cocaine dependence are related to one another: a secondary analysis. Drug Alcohol Depend:188135–188140
Lien L, Lien N, Heyerdahl S, Thoresen M, Bjertness E (2006) Consumption of soft drinks and hyperactivity, mental distress, and conduct problems among adolescents in Oslo, Norway. Am J Public Health 96(10):1815–1820
pubmed: 17008578
pmcid: 1586153
doi: 10.2105/AJPH.2004.059477
Manni C, Cipollone G, Pallucchini A, Maremmani AGI, Perugi G, Maremmani I (2019) Remarkable reduction of cocaine use in dual disorder (adult attention deficit hyperactive disorder/cocaine use disorder) patients treated with medications for ADHD. Int J Environ Res Public Health 16(20)
Maremmani AGI, Pallucchini A, Manni C, Cipollone G, Della Rocca F et al (2020) Can the psychopathology specific to substance use disorder distinguish between reward and relief craving? Heroin Addict Relat Clin Probl 22(5):5–11
Maremmani I, Pacini M (2003) Understanding the pathogenesis of drug addiction in order to implement a correct pharmacological intervention. Heroin Addict Relat Clin Probl 5(3):5–12
Mariani JJ, Khantzian EJ, Levin FR (2014) The self-medication hypothesis and psychostimulant treatment of cocaine dependence: an update. Am J Addict 23(2):189–193
pubmed: 25187055
doi: 10.1111/j.1521-0391.2013.12086.x
Medscape (2020) ADHD meds may boost treatment retention in comorbid addiction [Online]. Accessed 15 Dec 2020
Michels N, Sioen I, Braet C, Eiben G, Hebestreit A et al (2012) Stress, emotional eating behaviour and dietary patterns in children. Appetite 59(3):762–769
pubmed: 22918173
doi: 10.1016/j.appet.2012.08.010
Molina BS, Pelham WE Jr (2014) Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research. Annu Rev Clin Psychol:10607–10639
Oliva F, Mangiapane C, Nibbio G, Berchialla P, Colombi N et al (2020) Prevalence of cocaine use and cocaine use disorder among adult patients with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. J Psychiatr Res 143:587–598
pubmed: 33199055
doi: 10.1016/j.jpsychires.2020.11.021
Ortal S, Van De Glind G, Johan F, Itai B, Nir Y et al (2015) The role of different aspects of impulsivity as independent risk factors for substance use disorders in patients with ADHD: a review. Curr Drug Abuse Rev 8(2):119–133
pubmed: 26373850
doi: 10.2174/1874473708666150916112913
Pallucchini A, Carli M, Scarselli M, Maremmani I, Perugi G (2021) Symptomatological subtypes and related clinical features in adult attention deficit hyperactive disorder. Int J Environ Res Public Health 8(922). https://doi.org/10.3390/ijerph18030922
Parrott AC (2018) Mood fluctuation and psychobiological instability: the same core functions are disrupted by novel psychoactive substances and established recreational drugs. Brain Sci 8(3)
Perugi G, Pallucchini A, Rizzato S, De Rossi P, Sani G et al (2019) Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (Sud). Expert Opin Pharmacother 20(3):343–355
pubmed: 30513231
doi: 10.1080/14656566.2018.1551878
Reimherr FW, Roesler M, Marchant BK, Gift TE, Retz W et al (2020) Types of adult attention-deficit/hyperactivity disorder: a replication analysis. J Clin Psychiatry 81(2)
Riggs PD, Winhusen T, Davies RD, Leimberger JD, Mikulich-Gilbertson S et al (2011) Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry 50(9):903–914
pubmed: 21871372
pmcid: 3164797
doi: 10.1016/j.jaac.2011.06.010
Riley A, Spiel G, Coghill D, Döpfner M, Falissard B et al (2006) Factors related to health-related quality of life (hrqol) among children with ADHD in Europe at entry into treatment. Eur Child Adolescent Psychiatry 15(1):i38–i45
doi: 10.1007/s00787-006-1006-9
Rubio Morell B, Hernández Expósito S (2019) Differential long-term medication impact on executive function and delay aversion in ADHD. Appl Neuropsychol Child 8(2):140–157
pubmed: 29244542
doi: 10.1080/21622965.2017.1407653
Rucklidge JJ (2010) Gender differences in attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 33(2):357–373
pubmed: 20385342
doi: 10.1016/j.psc.2010.01.006
Sanford AE, Castillo E, Gannon RL (2008) Cannabinoids and hamster circadian activity rhythms. Brain Res:1222141–1222148
Schmitt K, Gold A, Rauch WA (2012) Defizitäre adaptive emotions- regulation bei kindern mit adhs. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 40(2):95
pubmed: 22354493
doi: 10.1024/1422-4917/a000156
Schubiner H, Saules KK, Arfken CL, Johanson CE, Schuster CR et al (2002) Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 10(3):286–294
pubmed: 12233989
doi: 10.1037/1064-1297.10.3.286
Schwartz DL, Gilstad-Hayden K, Carroll-Scott A, Grilo SA, Mccaslin C et al (2015) Energy drinks and youth self-reported hyperactivity/inattention symptoms. Acad Pediatr 15(3):297–304
pubmed: 25676784
pmcid: 4772143
doi: 10.1016/j.acap.2014.11.006
Sebastian A, Retz W, Tüscher O, Turner D (2019) Violent offending in borderline personality disorder and attention deficit/hyperactivity disorder. Neuropharmacology 156:107565
Shaw P, Stringaris A, Nigg J, Leibenluft E (2014) Emotion dysregulation in attention deficit hyperactivity disorder. Am J Psychiatry 171(3):276–293
pubmed: 24480998
pmcid: 4282137
doi: 10.1176/appi.ajp.2013.13070966
Skirrow C, Asherson P (2013) Emotional lability, comorbidity and impairment in adults with attention-deficit hyperactivity disorder. J Affect Disord 147(1–3):80–86
pubmed: 23218897
doi: 10.1016/j.jad.2012.10.011
Spera V, Pallucchini A, Carli M, Maiello M, Maremmani AGI et al (2020) Substance use disorder in adult-attention deficit hyperactive disorder patients: patterns of use and related clinical features. Int J Environ Res Public Health 17:3509
pmcid: 7277475
doi: 10.3390/ijerph17103509
Spera V, Pallucchini A, Carli M, Maiello M, Maremmani AGI et al (2021) Does cannabis, cocaine and alcohol use impact differently on adult attention deficit/hyperactivity disorder clinical picture? J Clin Med 10:1481
pubmed: 33918432
pmcid: 8038274
doi: 10.3390/jcm10071481
Stringaris A, Goodman R (2009) Longitudinal outcome of youth oppositionality: irritable, headstrong, and hurtful behaviors have distinctive predictions. J Am Acad Child Adolesc Psychiatry 48(4):404–412
pubmed: 19318881
doi: 10.1097/CHI.0b013e3181984f30
Stringaris A, Cohen P, Pine DS, Leibenluft E (2009) Adult outcomes of youth irritability: a 20-year prospective community-based study. Am J Psychiatry 166(9):1048–1054
pubmed: 19570932
pmcid: 2791884
doi: 10.1176/appi.ajp.2009.08121849
Surman CB, Biederman J, Spencer T, Yorks D, Miller CA et al (2011) Deficient emotional self-regulation and adult attention deficit hyperactivity disorder: a family risk analysis. Am J Psychiatry 168(6):617–623
pubmed: 21498464
doi: 10.1176/appi.ajp.2010.10081172
Surman CB, Biederman J, Spencer T, Miller CA, Mcdermott KM, Faraone SV (2013) Understanding deficient emotional self-regulation in adults with attention deficit hyperactivity disorder: a controlled study. Atten Defic Hyperact Disord 5(3):273–281
pubmed: 23413201
pmcid: 4009378
doi: 10.1007/s12402-012-0100-8
United Nations Office on Drugs and Crime (2016) World drug report. United Nations Publication Sales No. E.16.XI.7
Vaughn LK, Denning G, Stuhr KL, De Wit H, Hill MN, Hillard CJ (2010) Endocannabinoid signalling: has it got rhythm? Br J Pharmacol 160(3):530–543
pubmed: 20590563
pmcid: 2931554
doi: 10.1111/j.1476-5381.2010.00790.x
Verheul R, Van Den Brink W, Geerlings P (1999) A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol 34(2):197–222
pubmed: 10344781
doi: 10.1093/alcalc/34.2.197
Volkow ND, Wang GJ, Tomasi D, Kollins SH, Wigal TL et al (2012) Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. J Neurosci 32(3):841–849
pubmed: 22262882
pmcid: 3350870
doi: 10.1523/JNEUROSCI.4461-11.2012
Wehmeier PM, Schacht A, Barkley RA (2010) Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life. J Adolesc Health 46(3):209–217
pubmed: 20159496
doi: 10.1016/j.jadohealth.2009.09.009
Wender PH (1998) Attention-deficit hyperactivity disorder in adults. Psychiatr Clin North Am 21(4):761–774. v
pubmed: 9890120
doi: 10.1016/S0193-953X(05)70039-3
Wilens TE, Biederman J, Mick E (1998) Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict 7(2):156–163
pubmed: 9598219
Wilens TE, Faraone SV, Biederman J, Gunawardene S (2003) Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111(1):179–185
pubmed: 12509574
doi: 10.1542/peds.111.1.179
Wilens TE, Biederman J, Faraone SV, Martelon M, Westerberg D, Spencer TJ (2009) Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD. J Clin Psychiatry 70(11):1557–1562
pubmed: 20031097
pmcid: 2948439
doi: 10.4088/JCP.08m04785pur
Wilens TE, Prince JB, Waxmonsky J, Doyle R, Spencer T et al (2010) An open trial of sustained release bupropion for attention-deficit/hyperactivity disorder in adults with ADHD plus substance use disorders. J ADHD Relat Disord 1(3):25–35
pubmed: 22500195
pmcid: 3322541